[{"id":"8684fe35-4cc2-47ff-bb79-45f67ae9a6b4","acronym":"","url":"https://clinicaltrials.gov/study/NCT05068102","created_at":"2021-10-05T20:00:16.409Z","updated_at":"2024-07-02T16:35:00.041Z","phase":"Phase 1","brief_title":"A Study to Test How BI 765063 and BI 770371 Are Taken up in Tumours of People With Different Types of Advanced Cancer Who Are Also Taking Ezabenlimab","source_id_and_acronym":"NCT05068102","lead_sponsor":"Boehringer Ingelheim","biomarkers":" SIRPA","pipe":"","alterations":" ","tags":["SIRPA"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e ezabenlimab (BI 754091) • BI 765063 • BI 770371"],"overall_status":"Recruiting","enrollment":" Enrollment 13","initiation":"Initiation: 11/16/2021","start_date":" 11/16/2021","primary_txt":" Primary completion: 01/17/2025","primary_completion_date":" 01/17/2025","study_txt":" Completion: 03/21/2025","study_completion_date":" 03/21/2025","last_update_posted":"2024-05-30"}]